Related Experiment Video
Updated: Jun 18, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Immune-based therapeutics for pediatric cancer
Christian M Capitini1, Crystal L Mackall, Alan S Wayne
1National Cancer Institute, National Institutes of Health, Center for Cancer Research, Pediatric Oncology Branch, 10 Center Drive, MSC 1104, Bethesda, MD 20892, USA. capitinic@mail.nih.gov
Expert Opinion on Biological Therapy
|December 2, 2009
Summary
Novel immunotherapies show promise in treating pediatric cancers, offering alternatives to chemotherapy and overcoming resistance. Further research is needed to optimize and integrate these treatments into standard care for childhood cancer.
Area of Science:
- Pediatric oncology
- Cancer immunotherapy
- Tumor biology
Background:
- Standard cancer treatments face limitations like chemotherapy resistance and toxicity.
- Novel immune-based therapies offer promising alternatives for pediatric malignancies.
- Advances in tumor biology and lab technologies are driving progress in cancer immunotherapy.
Purpose of the Study:
- To review current immunotherapeutic clinical trials in pediatric oncology.
- To discuss the scientific basis for the development of these novel therapies.
Main Methods:
- Review of current immunotherapeutic clinical trials in pediatric oncology.
- Analysis of the scientific principles underlying the development of these therapies.
Main Results:
- Most immune-based therapies have been well-tolerated in pediatric patients.
- Immunotherapy demonstrates potential in overcoming chemotherapy resistance in refractory or high-risk cancers.
- Some immunotherapies have shown promise in clinical trials for pediatric malignancies.
Conclusions:
- Certain immunotherapies (e.g., ch14.18, MTP-PE) are effective in Phase III trials.
- Further studies are required to optimize and integrate other immunotherapies into standard treatment regimens.
- Randomized trials are needed to evaluate new immunotherapies for childhood cancer patients.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...